Retraction Note: Effect of preischemic treatment with fenofibrate, a peroxisome proliferator-activated receptor-α ligand, on hepatic ischemia–reperfusion injury in rats

被引:0
|
作者
Vivian Boshra
Amal M. Moustafa
机构
[1] Mansoura University,Department of Clinical Pharmacology, Faculty of Medicine
[2] Mansoura University,Department of Histology and Cytology, Faculty of Medicine
来源
关键词
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:495 / 495
相关论文
共 50 条
  • [21] Losartan attenuates hepatic ischemia/reperfusion injury through peroxisome proliferator-activated receptor-γ activation and the downregulation of the receptor for advanced glycation end products
    Yoon, Seong-Jin
    Koh, Eun-Ji
    Lee, Sun-Mee
    HEPATOLOGY, 2012, 56 : 320A - 320A
  • [22] Activation of peroxisome proliferator-activated receptor-α by fenofibrate prevents myocardial dysfunction during endotoxemia in rats
    Jozefowicz, Elsa
    Brisson, Helene
    Rozenberg, Sandrine
    Mebazaa, Alexandre
    Gele, Patrick
    Callebert, Jacques
    Lebuffe, Gilles
    Vallet, Benoit
    Bordet, Regis
    Tavernier, Benoit
    CRITICAL CARE MEDICINE, 2007, 35 (03) : 856 - 863
  • [23] Triglyceridemia and peroxisome proliferator-activated receptor-α expression are not connected in fenofibrate-treated pregnant rats
    Soria, A
    González, MD
    Vidal, H
    Herrera, E
    Bocos, C
    MOLECULAR AND CELLULAR BIOCHEMISTRY, 2005, 273 (1-2) : 97 - 107
  • [24] Peroxisome proliferator-activated receptor β/δ agonism protects the kidney against ischemia/reperfusion injury in diabetic rats
    Collino, Massimo
    Benetti, Elisa
    Miglio, Gianluca
    Castiglia, Sara
    Rosa, Arianna Carolina
    Aragno, Manuela
    Thiemermann, Christoph
    Fantozzi, Roberto
    FREE RADICAL BIOLOGY AND MEDICINE, 2011, 50 (02) : 345 - 353
  • [25] A specific peroxisome proliferator-activated receptor-γ (PPAR-γ) ligand, pioglitazone, ameliorates gastric mucosal damage induced by ischemia and reperfusion in rats
    Ichikawa, H
    Naito, Y
    Takagi, T
    Tomatsuri, N
    Yoshida, N
    Yoshikawa, T
    REDOX REPORT, 2002, 7 (05) : 343 - 346
  • [26] Activation of peroxisome proliferator-activated receptor-γ during hepatic ischemia is age-dependent
    Shin, Thomas
    Kuboki, Satoshi
    Huber, Nadine
    Eismann, Thorsten
    Galloway, Elizabeth
    Schuster, Rebecca
    Blanchard, John
    Pritts, Timothy A.
    Lentsch, Alex B.
    JOURNAL OF SURGICAL RESEARCH, 2008, 147 (02) : 200 - 205
  • [27] Catalposide is a natural agonistic ligand of peroxisome proliferator-activated receptor-α
    Lee, Ji Hae
    Jun, Hee-jin
    Hoang, Minh-Hien
    Jia, Yaoyao
    Han, Xiang Hua
    Lee, Dong-Ho
    Lee, Hak-Ju
    Hwang, Bang Yeon
    Lee, Sung-Joon
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2012, 422 (04) : 568 - 572
  • [28] Inhibition of corneal neovascularization by a peroxisome proliferator-activated receptor-γ ligand
    Sarayba, MA
    Li, L
    Tungsiripat, T
    Liu, NH
    Sweet, PM
    Patel, AJ
    Osann, KE
    Chittiboyina, A
    Benson, SC
    Pershadsingh, HA
    Chuck, RS
    EXPERIMENTAL EYE RESEARCH, 2005, 80 (03) : 435 - 442
  • [29] Flexible ligand recognition of peroxisome proliferator-activated receptor-γ (PPARγ)
    Yamagishi, Kenji
    Yamamoto, Keiko
    Mochizuki, Yuji
    Nakano, Tatsuya
    Yamada, Sachiko
    Tokiwa, Hiroaki
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2010, 20 (11) : 3344 - 3347
  • [30] The Role of Peroxisome Proliferator-Activated Receptor in Mediating Cardioprotection Against Ischemia/Reperfusion Injury
    Zhong, Chong-Bin
    Chen, Xi
    Zhou, Xu-Yue
    Wang, Xian-Bao
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY AND THERAPEUTICS, 2018, 23 (01) : 46 - 56